Latest Parkinson's disease Stories
NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease.
FPRT Bio works closely with academic leaders and research organizations to advance the use of XPro1595 in the treatment of Parkinson’s disease. Dallas, Texas
Parkinson’s disease affects neurons in the Substantia nigra brain region – their mitochondrial activity ceases and the cells die.
REHOVOT, Israel, August 4, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd.
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition
VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson’s disease.
ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million.
More Than 30 Scientific Projects Chosen for Potential to Improve the Lives and Futures of People Touched by Parkinson's NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- The Parkinson's
More Images (1 images) »